CEO Executive AssistantAccountable Care Organization Coordination Demands Executive Attention Backed by Administrative Precision
Accountable care organization coordination sits at the intersection of clinical performance, federal regulatory compliance, payer relationships, and financial strategy. For healthcare CEOs, overseeing an ACO program under CMS’s Medicare Shared Savings Program (MSSP) or a commercial ACO arrangement means managing performance against quality benchmarks, attribution methodology, network composition, and shared savings or risk-sharing calculations, all while keeping the board informed and aligned with the organization’s broader value-based care strategy.
The administrative complexity that surrounds accountable care organization coordination is substantial. CMS reporting cycles have fixed deadlines that do not flex. Quality metric requirements span dozens of measures. Payer alignment meetings involve external counterparties with their own priorities and timelines. Board reporting on ACO performance must be accurate, contextualized, and connected to the organization’s long-term strategic commitments.
An executive assistant who owns the scheduling, tracking, and briefing architecture for the ACO program enables the CEO to engage each of these workstreams with current information, consistent preparation, and the executive presence that complex stakeholder relationships require. This article explains the specific administrative disciplines that support healthcare CEOs leading ACO strategy at scale.
Scheduling CMS MSSP Performance Review Meetings
The Medicare Shared Savings Program operates on an annual performance year, with CMS providing preliminary and final financial reconciliation reports that determine whether an ACO has achieved shared savings or incurred shared losses. The reporting calendar is fixed by CMS, and the CEO needs to be engaged at the key moments in that cycle, from mid-year data releases to the final reconciliation, to understand the ACO’s trajectory and make strategic decisions before the performance year closes.
The EA establishes a CMS reporting calendar that maps all key MSSP data releases and reporting deadlines for the current performance year. This includes the mid-year benchmark data release, the preliminary financial results, the final financial reconciliation, and any quality performance reporting windows. The EA schedules CEO briefings timed to each release, with enough lead time for the ACO analytics and finance teams to prepare synthesized summaries rather than raw data outputs.
The CEO’s MSSP performance review sessions should focus on the decisions and strategic questions that require executive input: whether the ACO’s shared savings trajectory warrants a change in care management resource deployment, whether the benchmark methodology changes introduced by CMS require a strategic response, and whether the ACO’s performance supports the organization’s case for advancing to a higher-risk track. The EA structures these sessions to surface those questions directly, rather than allowing the meeting to become a data recitation.
When CMS announces significant changes to MSSP rules, including benchmark methodology updates, quality measure changes, or participation track modifications, the EA coordinates a briefing from the government affairs and ACO operations teams before the CEO is asked to comment publicly or respond to board or partner inquiries. Regulatory changes to MSSP can materially affect the ACO’s financial model, and the CEO needs to understand the implications before they become public knowledge.
The EA also tracks the calendar for CMS webinars, informal comment periods, and stakeholder engagement sessions related to MSSP rulemaking. When a proposed rule is open for comment and the organization has a material interest in the outcome, the EA ensures the government affairs and legal teams have the CEO’s input with enough lead time to incorporate it into a formal comment submission.
Coordinating Care Management Team Briefings
The care management function is the operational core of an ACO’s clinical strategy. Care managers, care coordinators, population health nurses, and social workers work with attributed beneficiaries to close care gaps, manage high-risk patients, prevent avoidable hospitalizations, and improve chronic disease management. Their work is what drives the quality performance and cost reduction that generate shared savings.
The CEO’s engagement with the care management team is strategic, not operational, but it must be consistent and informed. The EA coordinates regular briefings between the CEO and the ACO’s care management leadership, typically on a monthly cadence, covering population health performance, high-cost cohort management, care gap closure rates, and any operational barriers that require executive support to resolve.
These briefings serve two purposes: they keep the CEO current on the clinical performance of the ACO, and they signal to the care management leadership that the CEO considers their work a strategic priority. The latter is not trivial. Care management teams in health systems often lack visibility into how executive leadership perceives and values their work, and consistent CEO engagement reinforces organizational commitment to the ACO’s clinical model.
The EA prepares the briefing structure with the care management leadership in advance, ensuring each session covers the key performance indicators that the CEO has designated as the primary accountability metrics, rather than allowing the briefing to become a general update with no clear executive takeaways. The pre-read for each session includes a one-page summary of performance against these metrics, any significant changes in population composition or risk scores, and the team’s highest-priority requests for executive support.
When a care management initiative requires cross-functional coordination at the executive level, such as a new high-risk patient transition program that requires commitments from hospital medicine, post-acute care, and primary care leadership simultaneously, the EA facilitates the CEO’s convening role by coordinating the stakeholder meeting, preparing the agenda, and tracking action items to completion.
Tracking Shared Savings and Quality Metric Reporting Cycles
ACO performance is measured on two dimensions: financial performance (whether the ACO’s total cost of care is below its CMS benchmark) and quality performance (whether the ACO meets the quality thresholds required to receive its full shared savings allocation). Both dimensions have reporting cycles that the CEO must track, and both interact with each other in ways that require executive understanding.
The EA owns the quality metric reporting calendar. CMS updates ACO quality measure requirements annually, and the current MSSP quality reporting framework requires ACOs to report on a set of measures spanning preventive care, chronic disease management, patient experience, and care coordination. The EA maps each required measure to its data collection methodology, reporting submission deadline, and internal ownership, and builds a master reporting calendar that shows the CEO at a glance which measures are on track and which are at risk.
For measures that rely on claims-based calculation by CMS, the EA ensures the CEO understands the lag between care delivery and measure calculation, which affects how the organization interprets mid-year quality performance data. For measures that require active data submission by the ACO, the EA tracks submission deadlines and coordinates with the quality team to confirm submissions are complete and accurate before the window closes.
Shared savings calculations involve actuarial complexity that the CEO must be able to explain clearly to the board and to external partners. The EA coordinates a quarterly financial summary from the ACO analytics and finance teams that translates the CMS benchmark comparison into a clear projection of the ACO’s likely shared savings or shared losses for the performance year, along with the confidence interval around that projection and the key variables that could move the outcome in either direction.
When quality performance on a specific measure is lagging in a way that could affect the ACO’s shared savings multiplier or create a performance improvement plan obligation with CMS, the EA ensures this is flagged to the CEO with enough lead time for corrective action, not after the performance year has closed. Early warning requires a reporting cadence that surfaces problems in time to address them, and the EA’s tracking discipline is what makes that possible.
For EAs who also support the healthcare CEO’s strategic planning processes that frame the ACO program’s long-term development, strategic planning coordination provides a detailed framework for the administrative disciplines that connect ACO strategy to the organization’s broader enterprise planning cycles.
Managing Payer Alignment Meetings for Value-Based Contracts
Commercial ACO arrangements and value-based contracts with major payers, including Medicare Advantage plans, Medicaid managed care organizations, and commercial insurance carriers, require active relationship management at the executive level. These contracts set the financial terms under which the organization is rewarded or penalized for cost and quality performance, and the CEO’s engagement with payer counterparts is a strategic asset that affects both the terms of existing contracts and the organization’s ability to negotiate favorable arrangements in the future.
The EA coordinates the CEO’s payer relationship calendar by maintaining a map of the organization’s active value-based contracts, the payer contacts at the appropriate executive level, and the contract review and renewal timeline for each agreement. For contracts that are approaching renewal, the EA ensures the CEO is briefed on the current contract performance and the organization’s negotiating priorities well before the renewal conversation begins with the payer.
For each major payer relationship, the EA schedules at least an annual executive-level meeting between the CEO and the payer’s senior leadership. These meetings serve as relationship maintenance sessions that operate above the transactional level of claims disputes and operational issues, and they create a channel for strategic dialogue about where both organizations want to take the value-based relationship over the coming years. The EA prepares the CEO for these meetings with a briefing document covering the contract’s performance metrics, any open operational issues the CEO should be aware of, and the agenda for the executive discussion.
When a payer proposes a material change to contract terms, introduces a new value-based arrangement, or raises a concern about the organization’s performance under an existing contract, the CEO needs to be engaged before the negotiating position is set. The EA coordinates the internal preparation session, bringing together the managed care, finance, legal, and clinical teams to assess the proposal and develop the organization’s response, before scheduling the external meeting with the payer.
The EA also tracks the Medicare Advantage market developments and Medicaid managed care contracting environment in the organization’s primary markets, ensuring the CEO receives periodic briefings on market-level changes that could affect the organization’s value-based portfolio. CMS policy changes affecting MA benchmark methodology, risk adjustment, or star ratings directly affect the payer’s financial position and their appetite for value-based arrangements, and the CEO needs to understand these dynamics to engage payers as an informed peer.
Preparing Board Presentations on ACO Performance, Attribution Rates, and Network Development Strategy
Board presentations on the ACO program must give directors a clear, accurate picture of the program’s clinical and financial performance, explain the attribution methodology in terms that non-clinical board members can understand, and connect ACO development strategy to the organization’s broader value-based care transition and financial sustainability goals.
The EA manages the ACO board presentation prep process with a structured timeline beginning three weeks before each board meeting. They identify the sections of the ACO update the CEO will present, establish ownership for each section, set draft submission deadlines, and schedule the CEO’s review session with time for revisions. Version control is the EA’s responsibility: the CEO and all contributors should always be working from the current draft, not a prior version.
The core metrics for an ACO board presentation include: attributed beneficiary count and attribution rate trend, total cost of care performance against CMS benchmark, projected shared savings or shared losses for the performance year, quality measure performance by domain, and any significant changes in network composition or provider participation. The EA ensures these metrics are presented consistently across board sessions using a standardized format that allows directors to track program evolution over multiple years.
Attribution rate deserves particular attention in board presentations because it is the population measure that determines the ACO’s scale and financial relevance. If the organization is losing attribution to competing providers or if the ACO’s attribution logic is misaligned with beneficiary care patterns, these are strategic issues that the board needs to understand. The EA coordinates with the ACO analytics team to ensure attribution trends are explained clearly, with the drivers of any material change identified and addressed in the CEO’s narrative.
Network development strategy is the forward-looking section of the ACO board presentation, covering the organization’s plans to add provider partners, expand into new service areas, or deepen care management capabilities in response to the program’s performance trajectory. The CEO’s articulation of this strategy must be grounded in the ACO’s current performance data and connected to the financial targets the board has approved. The EA ensures the strategy section of the presentation is coordinated with the CEO’s enterprise strategy team, so it is consistent with the organization’s broader market development plans.
According to McKinsey’s analysis of value-based care adoption, health systems that achieve sustainable shared savings in ACO programs combine rigorous population health analytics with executive-level commitment to care transformation and network discipline. The EA who builds the administrative infrastructure that enables consistent executive engagement across all three dimensions is enabling clinical and financial outcomes that extend well beyond administrative efficiency.
Accountable Care Organization Coordination Requires Administrative Infrastructure That Matches Program Complexity
Healthcare CEOs who lead ACO programs effectively do so because their administrative infrastructure keeps every workstream running in parallel: CMS performance reviews on cadence, care management briefings current and structured, quality reporting tracked to deadline, payer relationships maintained at the executive level, and board presentations grounded in verified data.
An EA who owns this infrastructure ensures that accountable care organization coordination receives the executive attention it requires without consuming executive bandwidth that the CEO needs for clinical leadership, enterprise strategy, and external relationships. The ACO program is increasingly central to how health systems sustain financial performance in a value-based environment. The administrative support behind it should be equal to that importance.